205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.26%
Net income growth under 50% of MRVL's 92.00%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.07%
Negative yoy D&A while MRVL is 2.32%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-111.86%
Negative yoy deferred tax while MRVL stands at 71.43%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-26.32%
Both cut yoy SBC, with MRVL at -14.20%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
4400.00%
Slight usage while MRVL is negative at -93.07%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-28.95%
AR is negative yoy while MRVL is 253.90%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
195.77%
Inventory growth well above MRVL's 205.80%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-76.92%
Both negative yoy AP, with MRVL at -977.86%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
155.26%
Some yoy usage while MRVL is negative at -95.97%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-72.00%
Negative yoy while MRVL is 657.37%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
32.18%
Operating cash flow growth below 50% of MRVL's 150.50%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
12.03%
Lower CapEx growth vs. MRVL's 47.42%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-12.03%
Both yoy lines negative, with MRVL at -162.50%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
1.51%
Some yoy expansion while MRVL is negative at -103.77%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-57.44%
We reduce yoy sales while MRVL is 60.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
7.89%
We have some outflow growth while MRVL is negative at -78.69%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-1027.69%
Both yoy lines negative, with MRVL at -90.66%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-20.21%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
5.12%
Buyback growth below 50% of MRVL's 62.76%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.